This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Astrazeneca Ab, Targacept, Inc.. Active years: 2011-2014.
Company Filing History:
Years Active: 2011-2014
Title: Thomas Wännman: Innovator in Chemical Processes
Introduction
Thomas Wännman is a notable inventor based in Södertälje, Sweden. He has made significant contributions to the field of chemistry, particularly in the development of processes for synthesizing complex chemical compounds. With a total of 2 patents to his name, Wännman's work has implications in various applications within the pharmaceutical industry.
Latest Patents
Wännman's latest patents include a process for the preparation of aryl substituted olefinic amines. This innovative process focuses on creating compounds such as (2S)-(4E)-N-methyl-5-[3-(5-isopropoxypyridin)yl]-4-penten-2-amine and (2S)-(4E)-N-methyl-5-[3-(5-methoxypyridin)yl]-4-penten-2-amine, along with new intermediates used in the process. Additionally, he has developed a process for the synthesis of alkyl phosphinic acids, which involves a coupling reaction between an alkyl halide and a hypophosphorous acid derivative in the presence of an amine and an amine oxide.
Career Highlights
Throughout his career, Thomas Wännman has worked with prominent companies in the pharmaceutical sector, including Targacept, Inc. and AstraZeneca AB. His experience in these organizations has allowed him to refine his skills and contribute to significant advancements in chemical processes.
Collaborations
Wännman has collaborated with notable professionals in his field, including Gary Maurice Dull and Per Olof Ryberg. These collaborations have further enriched his work and expanded the impact of his inventions.
Conclusion
Thomas Wännman is a distinguished inventor whose contributions to chemical processes have paved the way for advancements in the pharmaceutical industry. His innovative patents and collaborations highlight his commitment to enhancing chemical synthesis methods.